ATE171178T1 - N-(3-(2-(1h-imidazol-1-yl)ethoxy)phenyl)-4-(2- thienyl)-2-pyrimidinamin und pharmakologisch akzeptierbare salze - Google Patents

N-(3-(2-(1h-imidazol-1-yl)ethoxy)phenyl)-4-(2- thienyl)-2-pyrimidinamin und pharmakologisch akzeptierbare salze

Info

Publication number
ATE171178T1
ATE171178T1 AT92119890T AT92119890T ATE171178T1 AT E171178 T1 ATE171178 T1 AT E171178T1 AT 92119890 T AT92119890 T AT 92119890T AT 92119890 T AT92119890 T AT 92119890T AT E171178 T1 ATE171178 T1 AT E171178T1
Authority
AT
Austria
Prior art keywords
thienyl
ethoxy
phenyl
acceptable salts
pharmacologically acceptable
Prior art date
Application number
AT92119890T
Other languages
English (en)
Inventor
Rolf Paul
Robert Gerard Kelly
Lawrence W Torley
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Application granted granted Critical
Publication of ATE171178T1 publication Critical patent/ATE171178T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT92119890T 1991-12-31 1992-11-23 N-(3-(2-(1h-imidazol-1-yl)ethoxy)phenyl)-4-(2- thienyl)-2-pyrimidinamin und pharmakologisch akzeptierbare salze ATE171178T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/816,335 US5162328A (en) 1991-12-31 1991-12-31 N-[3-[2-(1H-imidazol-1-yl)ethoxy]phenyl]-4-(2-thienyl)-2-pyrimidinamine and pharmacologically acceptable salts

Publications (1)

Publication Number Publication Date
ATE171178T1 true ATE171178T1 (de) 1998-10-15

Family

ID=25220310

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92119890T ATE171178T1 (de) 1991-12-31 1992-11-23 N-(3-(2-(1h-imidazol-1-yl)ethoxy)phenyl)-4-(2- thienyl)-2-pyrimidinamin und pharmakologisch akzeptierbare salze

Country Status (16)

Country Link
US (1) US5162328A (de)
EP (1) EP0549880B1 (de)
JP (1) JPH05271227A (de)
KR (1) KR930012761A (de)
AT (1) ATE171178T1 (de)
AU (1) AU651539B2 (de)
CA (1) CA2086357A1 (de)
DE (1) DE69227015T2 (de)
DK (1) DK0549880T3 (de)
ES (1) ES2121809T3 (de)
FI (1) FI925951L (de)
HU (1) HUT66943A (de)
NO (1) NO301476B1 (de)
NZ (1) NZ245513A (de)
SG (1) SG47556A1 (de)
ZA (1) ZA9210120B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7803806B2 (en) * 2005-11-03 2010-09-28 Sgx Pharmaceuticals, Inc. Pyrimidinyl-thiophene kinase modulators

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2087056T3 (es) * 1986-01-13 1996-07-16 American Cyanamid Co 2-pirimidinaminas sustituidas en las posiciones 4, 5 y 6.
US4788195A (en) * 1986-01-13 1988-11-29 American Cyanamid Company 4,5,6-substituted-N-(substituted-phenyl)-2-pyrimidinamines

Also Published As

Publication number Publication date
EP0549880B1 (de) 1998-09-16
ZA9210120B (en) 1994-04-12
NO924760D0 (no) 1992-12-09
DE69227015D1 (de) 1998-10-22
AU651539B2 (en) 1994-07-21
FI925951A7 (fi) 1993-07-01
HU9204172D0 (en) 1993-04-28
US5162328A (en) 1992-11-10
NO301476B1 (no) 1997-11-03
CA2086357A1 (en) 1993-07-01
FI925951A0 (fi) 1992-12-30
NZ245513A (en) 1994-07-26
JPH05271227A (ja) 1993-10-19
ES2121809T3 (es) 1998-12-16
AU3046292A (en) 1993-07-08
FI925951L (fi) 1993-07-01
HUT66943A (en) 1995-01-30
NO924760L (no) 1993-07-01
DK0549880T3 (da) 1999-06-14
KR930012761A (ko) 1993-07-21
SG47556A1 (en) 1998-04-17
DE69227015T2 (de) 1999-03-25
EP0549880A1 (de) 1993-07-07

Similar Documents

Publication Publication Date Title
NO933093L (no) Monohydrat av 5-(2-(4-(1,2-benzisotiazol-3-yl)-1-piperazinyl)-etyl)-6-klor-1,3-dihydro-2H-indol-2-on hydroklorid
DK0957099T3 (da) Heterocykliske carboxamider
UY26480A1 (es) Inhibidores de n - (5 - ( 5 - alquil - 2 - oxazolil) metil ) tio) - 2 - tiazolil) - carboxamida de cinasas dependientes de ciclina
EA199800909A1 (ru) Тригидрат мезилата 5-(2-(4-(1,2-бензизотиазол-3-ил)пиперазин-1-ил)этил)-6-хлор-1,3-дигидро-2н-индол-2-она, фармацевтическая композиция и способ лечения психического расстройства
DK0388054T3 (da) Pyrrolidin-derivater
NO964950L (no) Krystallinsk hydroklorid av (R)-(-)-2-{N-£4-(1,1-dioksido-3-okso-2,3-dihydro-benziso-tiazol-2-yl)-butyl|-aminometyl}-kroman
UY26481A1 (es) Inhibidores de n - (5 - ( ( (5 - alquil - 2 - oxazolil) metil) tio) - 2 - tiazolil) - carboxamida de cinasas dependientes de ciclina.
MY119997A (en) Mesylate dihydrate salts of 5-(2-(4-(1, 2-benzisothiazol-3-yl) -1-piperazinyl)-6-chloro-1, 3- dihydro-2h-indol-2-one
TR200001872A3 (tr) 4-[5-(4-Metilfenil-3-(triflorometil)-1H-pirazol-1-il] benzensulfonamit' in yeni kristal biçimi "Biçim I" ve bu ürünün üretilmesine iliskin yöntem.
NZ528997A (en) Sulfonamides
DK0474580T3 (da) Anvendelse af 1-(3-dimethylamino)propyl)-1-phenylphthalener til behandling af cerebrovaskulære sygdomme
DE69323667D1 (de) 4-substituierte 1,2,4-Triazolderivate
HUP9802995A2 (hu) Szubsztituált szulfonil-amino-(tio)karbonil-származékok, intermedierjeik, a vegyületeket hatóanyagként tartalmazó herbicid készítmények, valamint eljárás a vegyületek, és készítmények előállítására és alkalmazására
KR880006196A (ko) 알레르기 및 염증 치료제인 디하이드로피리딘
PT790236E (pt) Pro-farmacos de 5-(2-(4-(1,2-benzisotiazol-3-il)-1-piperazinil)-etil-6-cloro-1,3-di-hidro-2h-indol-2-ona
ATE171178T1 (de) N-(3-(2-(1h-imidazol-1-yl)ethoxy)phenyl)-4-(2- thienyl)-2-pyrimidinamin und pharmakologisch akzeptierbare salze
TW369528B (en) Alpha-substituted benzyl heterocyclic derivatives, a process for producing intermediates and containing the same as a fungicide or insecticide active ingredient
BR0201569A (pt) 4-(2-piridil) piperizinas possuindo uma atividade agonista do receptor 5ht7
ATE293961T1 (de) Verwendung von hydantoin und seinen derivaten gegen hypalbuminämie
DE60212434D1 (de) Rosiglitazon-edisylate und ihre verwendung als antidiabetika
FI964114L (fi) Uusia 1-(5-metaanisulfonamidoindolyyli-2-karbonyyli)-4-(3-(1-metyylietyyliamino)-2-pyridinyyli)piperatsiinin kiteisiä muotoja
DE50003959D1 (de) Verfahren zur Herstellung von N-[5-(Diphenylphosphinoylmethyl)-4-(4-fluorphenyl)-6-isopropylpyrimidin-2-yl]-N-methylmethansulfonamid
UY24465A1 (es) Antagonistas oxadiazol y tiadiazol del receptor muscarinico

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee